Literature DB >> 12525588

Pregnancy outcomes after fallopian tube recanalization: oil-based versus water-soluble contrast agents.

Anil B M Pinto1, David M Hovsepian, Saranya Wattanakumtornkul, Thomas K Pilgram.   

Abstract

PURPOSE: To determine the pregnancy outcomes in patients undergoing fallopian tube recanalization (FTR) with use of oil-based versus water-soluble contrast agents.
MATERIALS AND METHODS: Ninety-three patients with unilateral or bilateral proximal tubal occlusion confirmed by hysterosalpingography or laparoscopy underwent FTR with use of water-soluble contrast material alone (n = 50) or also had an oil-based agent injected into each tube after recanalization (n = 43). Pregnancy rates and outcomes of the two groups were studied retrospectively.
RESULTS: With respect to differences between groups, only the body mass index proved to be a significant predictor (oil, 28.4; water, 24.7; P =.008). Mean age, duration of infertility, type of infertility, and initial diagnosis were comparable. There was a weak trend toward a higher pregnancy rate in the oil-based contrast material group, but it was not significant (P =.64). The average time to pregnancy was 4.4 months with use of oil-based contrast material, compared to 7.7 months with use of only water-soluble contrast material (P =.03).
CONCLUSION: The use of an oil-based agent had little effect on the rate of conception, but time to conception was reduced by more than 3 months.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12525588     DOI: 10.1097/01.rvi.0000052293.26939.10

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  2 in total

1.  Prophylactic antibiotic guidelines in modern interventional radiology practice.

Authors:  Eunice Moon; Matthew D B S Tam; Raghid N Kikano; Karunakaravel Karuppasamy
Journal:  Semin Intervent Radiol       Date:  2010-12       Impact factor: 1.513

2.  Conception rates after fluoroscopy-guided fallopian tubal cannulation: an alternative to in vitro fertilization for patients with tubal occlusion.

Authors:  Jeffrey W Wang; Gabriella M Rustia; Mary Wood-Molo; Jordan Tasse; David Tabriz; Ulku C Turba; Bulent Arslan; Sreekumar Madassery
Journal:  Ther Adv Reprod Health       Date:  2020-10-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.